Niu, Q., Wang, W., Li, Y., Ruden, D. M., Wang, F., Li, Y., . . . Zheng, K. (2012). Low Molecular Weight Heparin Ablates Lung Cancer Cisplatin-Resistance by Inducing Proteasome-Mediated ABCG2 Protein Degradation. Public Library of Science.
Citación estilo ChicagoNiu, Qi, Wei Wang, Yong Li, Douglas M. Ruden, Fenghua Wang, Yue Li, Fangying Wang, Jingying Song, y Kun Zheng. Low Molecular Weight Heparin Ablates Lung Cancer Cisplatin-Resistance By Inducing Proteasome-Mediated ABCG2 Protein Degradation. Public Library of Science, 2012.
Cita MLANiu, Qi, et al. Low Molecular Weight Heparin Ablates Lung Cancer Cisplatin-Resistance By Inducing Proteasome-Mediated ABCG2 Protein Degradation. Public Library of Science, 2012.
Precaución: Estas citas no son 100% exactas.